NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
Sign in Subscribe

Private Equity Firms Eye One of History’s Largest Leveraged Buyouts for Global Payments

CD&R is teaming with top shareholder GTCR on a potential $40B takeover of Global Payments.

Private Equity Firms Eye One of History’s Largest Leveraged Buyouts for Global Payments
globalpayments.com/
Already have an account? Sign in.
Featured/ 10/30/2026 · 3:37 PM
GPN
/ Don’t stop at just one post.

Related↓

BILL Holdings Explores Sale Amid Activist Pressure and Market Struggles
Featured/ 11/12/2025 · 6:16 AM

BILL Holdings Explores Sale Amid Activist Pressure and Market Struggles

BILL Holdings considers strategic options including potential sale as shares drop 45% this year. Business-payments firm works with adviser amid activist investor pressure.

/ Subscriber only
/ Read more

Feed↓

AstraZeneca Shares Rally as Strong Results and $1.5bn Savings Plan Shift Focus to Pipeline
Featured/ 10/30/2026 · 12:19 PM

AstraZeneca Beats Forecasts, Unveils Cost-Savings Drive to Fund Pipeline Growth

AstraZeneca posted solid 9M and Q3 results, beat forecasts, and launched a $1.5bn savings plan to fund its pipeline.

/ Subscriber only
Agios Shares Fall After FDA Extends Mitapivat Review for Sickle Cell Disease
10/30/2026 · 11:35 AM

Agios Shares Fall After FDA Extends Mitapivat Review for Sickle Cell Disease

FDA pushed back the mitapivat SCD decision to Feb 2027 after a major amendment. Agios stock dropped on the delay.

/ Subscriber only
Fund 1 Prepares Cash Bid to Take Club Pilates Owner Xponential Private
10/30/2026 · 10:15 AM

Fund 1 Prepares Cash Bid to Take Club Pilates Owner Xponential Private

Fund 1 Investments is preparing a $5.61–$7 per share cash bid to take Xponential Fitness private amid its ongoing strategic review.

/ Subscriber only
Explore
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
More
  • Sign up
  • Sign in
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Terms/Privacy
  • UP↑
Get alerts

Be the first to know when deals break, stocks move, or biotech headlines hit.

Email address Subscribe
DON'T FALL BEHIND. ©2026
For informational purposes only. Not financial advice.
NOTRELOAD AI